Cold News and Research

RSS

Novelos Therapeutics acquires Cellectar

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has completed its acquisition of Cellectar, Inc., a Wisconsin-based drug development company, in a stock-for-stock transaction.

12 Apr 2011

Researchers manage to grow human rhinovirus in culture using sinus tissue

Using sinus tissue removed during surgery at University of Wisconsin Hospital and Clinics, researchers at the University of Wisconsin-Madison have managed to grow a recently discovered species of human rhinovirus, the most frequent cause of the common cold, in culture.

11 Apr 2011

Some consumers left out of Anthem's delay to planned rate hikes

Although the insurer announced last month that it would delay a planned premium rate increase for about 600,000 policy holders, reports indicate that as many as 120,000 people will still experience the increases.

8 Apr 2011

Parents and schools may contribute to childhood obesity

Two of the biggest influences on children — parents and schools — may unintentionally contribute to childhood obesity. That's the observation of Susan Terwilliger, clinical associate professor in the Decker School of Nursing at Binghamton University, who studies the problem.

7 Apr 2011

U.S. Marshals, FDA seize $6 million worth Triad antiseptic products

U.S. Marshals, at the request of the U.S. Food and Drug Administration, today seized more than $6 million in products distributed by Triad Group Inc., at the company's facility in Hartland, Wis.

7 Apr 2011

Study suggests causal link between HSV1 and Alzheimer's disease

Laboratories at the University of New Mexico (UNM), Brown University, and House Ear Institute (HEI) have developed a new technique to observe herpes simplex virus type 1 (HSV1) infections growing inside cells. HSV1, the cause of the common cold sore, persists in a latent form inside nerve cells.

5 Apr 2011

Transgenomic to present study results of high-sensitivity cancer mutation assays at AACR

Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.

2 Apr 2011

Geisinger expert offers advice on how to manage child's asthma

Asthma is the leading cause of hospital visits and missed school days in children, according to the National Institute of Health. A chronic condition, pediatric asthma requires continual care to prevent serious, life-threatening asthma attacks.

1 Apr 2011

Pediatrician suggests tips to combat allergic symptoms

One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies.

1 Apr 2011

Hands-free electronic water faucets more likely to be contaminated with hazardous bacteria

A study of newly installed, hands-free faucets at The Johns Hopkins Hospital, all equipped with the latest electronic-eye sensors to automatically detect hands and dispense preset amounts of water, shows they were more likely to be contaminated with one of the most common and hazardous bacteria in hospitals compared to old-style fixtures with separate handles for hot and cold water.

1 Apr 2011

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its fourth quarter and full year financial results periods ended December 31, 2010.

31 Mar 2011

ACAAI to launch 15th annual Nationwide Asthma Screening Program

The nation's allergists help adults and children learn if they are at risk for asthma or exercise-induced bronchoconstriction as the American College of Allergy, Asthma and Immunology conducts its 15th annual Nationwide Asthma Screening Program.

31 Mar 2011

Transgenomic discovers novel BLOCker-Sequencing technology

Transgenomic, Inc. today announced that it has discovered a novel sequencing technology, which the company has termed BLOCker-Sequencing, which enhances the limit of detection of standard Sanger Sequencing, enriches for direct sequencing of mutated DNA over wild-type and can be run on standard Sanger Sequencing equipment.

30 Mar 2011

CHPA issues statement in response to anti-consumer law on cold and allergy drugs

The Consumer Healthcare Products Association today issued the following statement in response to passage of Senate Bill 437: "Legislation sponsored by Senator Percy Malone and now signed into law places new, onerous burdens on Arkansas families and makes it more difficult for those with common colds and allergies, even basic aches and pains, to get the medications they need. Unfortunately, Senate Bill 437 falls short of the common-sense approach Arkansans expect from their leaders."

28 Mar 2011

Almac extends Pharma Services business unit to increase demand for storage capacity

In response to increased client demand for cold and dedicated frozen storage capacity for biopharmaceuticals, Almac's Pharma Services business unit has expanded its commercial facilities to include an additional 6124 sq ft of cold and frozen storage.

25 Mar 2011

Mouse sperm created in lab: Hope for male infertility

In a scientific breakthrough, researchers report that they've grown mouse sperm from testicular tissue in the laboratory, a development that could advance the field of infertility in human males. Although still proven in mice, “this is a small but important step in understanding how sperm are formed, which may, in time, lead to us being able to grow human sperm in the laboratory,” said Dr. Allan Pacey, senior lecturer in andrology at the University of Sheffield in England, who is familiar with the study results.

24 Mar 2011

Drug resistance tuberculosis concerns

According to a report released Wednesday, the World Health Organization revealed that drug resistant tuberculosis (TB) accounts for about 440,000 cases and 150,000 deaths worldwide each year. The WHO called for better diagnosis and more funding for treatment of the drug-resistant disease that's harder to cure.

23 Mar 2011

Northwest Russian women breast milk consists of more POPs than Norwegian

Russian women living in Northwest Russia are more exposed to environmental toxins than Norwegian women. In spite of this, PhD candidate Anuschka Polder urges Russian women to breastfeed their babies.

22 Mar 2011

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application by the U.S. Food and Drug Administration.

22 Mar 2011

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

A physician affiliated with Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital (SLEH) is the first in Houston and among the first in the nation to treat patients for an irregular heartbeat with a new, minimally invasive cryoballoon technology that uses cold rather than heat to interrupt faulty electrical circuits in the heart.

21 Mar 2011